Stock Market Reviews

Read and share opinions on PCSA (Processa Pharmaceuticals, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock

Latest News

• Processa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025
  Nov 5, 2025
• Insider Stock Buyers At Processa Pharmaceuticals Recouped Some Losses This Week
  Aug 6, 2025
• Processa Pharmaceuticals and BullFrog AI Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
  Jul 18, 2025
• Processa Pharmaceuticals, Inc. (PCSA) Secures Buy Rating on Portfolio Progress
  Jul 11, 2025
• Processa Pharmaceuticals Provides Portfolio and Business Update
  Jul 1, 2025
• Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering
  Jun 17, 2025
• Processa Pharmaceuticals Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option to License Phase 2 Gastroparesis Drug Candidate
  Jun 17, 2025
• Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025
  Jun 13, 2025
• Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting
  May 30, 2025
• Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025
  Apr 15, 2025
• Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
  Mar 18, 2025
• Processa Pharmaceuticals, Inc. (PCSA): Among the Cheapest Stocks Insiders Are Buying Recently
  Feb 21, 2025
• Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference
  Feb 7, 2025
• Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
  Jan 30, 2025
• Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
  Jan 28, 2025